Model update planned · step 10 of your FDA journey

Change assessment

One planned change to your AI device, walked through the FDA's software-change and change-control-plan guidance, with a written reason for every answer.

From $2,500 · within a week of receiving the change description and risk file · quoted for your device · software and AI model changes today, read against the FDA's software-change and change-control-plan guidance

What you get

  • The FDA's questions answered in order, each with a written reason from your own documents
  • The result the guidance's flowchart points to, worded as the guidance words it
  • The change-control plans authorized in your product code, as precedent

PDF and Word, every statement footnoted to its source.

How it works

  1. 1

    Send one document, free

    A one-page reply in two working days on what we see and which service fits.

  2. 2

    Agree a fixed fee

    From $2,500. The fee for your device is fixed in writing before work starts.

  3. 3

    Receive the deliverable

    Your documents under a signed confidentiality agreement; delivered within a week of receiving the change description and risk file.

What we need from you

  • A description of the change and the version numbers
  • Your risk management file and specifications
  • Your authorized change-control plan, if you have one

Is it for you?

Right for you if you are asking

“Does this model update need a new submission, or is it covered by our change-control plan?”

Because

  • Every release raises the same question, and a change that needed a new 510(k) and did not get one is the costly answer.
  • The FDA's guidance asks specific questions about risk, risk controls and clinical performance; the reasons have to be written down.
  • Change-control plans are new: the FDA authorized 104 devices with one in 2025, against 29 in 2024.

Often bought by: ai device companies that retrain or update a cleared model; regulatory leads deciding whether a release needs a new 510(k); companies with an authorized pccp checking a change against it.

Not the right fit if

  • The device has no FDA authorization yet: the change questions apply to a device on the market, so start with the Pre-Sub package
  • You want the decision made for you: the assessment sets out the guidance's questions and your reasons; your regulatory lead decides

Questions

›Where does the data come from, and how accurate is it?

Software and AI model changes today, read against the FDA's software-change and change-control-plan guidance.

Every figure is traced to the FDA’s own record and dated.

›What doesn't it do?
  • A determination — whether a new submission is required is the manufacturer's to decide and the FDA's to judge
  • A review of the change's verification or validation data

The FDA decides. Every deliverable says so on its cover.

›What isn't included in the price?
  • The FDA's user fees and the annual establishment registration fee, paid by you to the FDA
  • Entering the content into eSTAR and sending it through the CDRH Portal, done by your team
  • Running tests or studies, or writing their protocols
  • Speaking for you to the FDA, in meetings or in writing

What the FDA charges →

›Can a consultant buy it for a client?

Yes, at 20% off, delivered under your firm’s name. How it works for consultants →

Change assessment · From $2,500The fee for your device is fixed in writing before work starts.Start with a free first read